3 Οκτωβρίου, 2025How to interpret MICs of amphotericin B, echinocandins and flucytosine against Candida auris (Candidozyma auris) according to the newly established European Committee for Antimicrobial Susceptibility Testing (EUCAST) breakpointsArendrup MC, Guinea J, Arikan-Akdagli S, Meijer EFJ, Meis JF, Buil JB, Dannaoui E, Giske CG, Lyskova P, Meletiadis J; Subcommittee on Antifungal Susceptibility Testing of […]
3 Οκτωβρίου, 2025A Global Analysis of Cases of Mucormycosis Recorded in the European Confederation of Medical Mycology / International Society for Human and Animal Mycology (ECMM / ISHAM) Zygomyco.net Registry from 2009 to 2022Skiada A, Drogari-Apiranthitou M, Roilides E, Chander J, Khostelidi S, Klimko N, Hamal P, Chrenkova V, Kanj SS, Zein SE, Lagrou K, Lass-Flörl C, Barac A, […]
3 Οκτωβρίου, 2025Candida auris vs. Non-Candida auris Candidemia in Critically Ill Patients: Clinical Outcomes, Risk Factors, and MortalityGülten E, Çınar G, Sarıcaoğlu EM, Akdemir İ, Yılmaz AZ, Saldere EH, Yörük F. J Fungi (Basel). 2025 Jul 24;11(8):552. doi: https://doi.org/10.3390/jof11080552
3 Οκτωβρίου, 2025Future Prospects and Challenges in Mucormycosis ResearchChamilos G, Binder U, Garre V. J Fungi (Basel). 2025 Jul 22;11(8):545. doi: https://doi.org/10.3390/jof11080545
3 Οκτωβρίου, 2025A humanized antibody against mucormycosis targets angioinvasion and augments the host immune responseGu Y, Singh S, Alqarihi A, Alkhazraji S, Gebremariam T, Youssef EG, Liu H, Fan X, Jiang WR, Andes D, Cochrane TR, Schwartz JA, Filler SG, […]